warfarinnatrium "2care4" 2,5 mg tabletter
2care4 aps - warfarinnatrium - tabletter - 2,5 mg
zoloft 25 mg filmovertrukne tabletter
2care4 aps - sertralinhydrochlorid - filmovertrukne tabletter - 25 mg
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
sertralin "zentiva" 25 mg filmovertrukne tabletter
zentiva k.s. - sertralinhydrochlorid - filmovertrukne tabletter - 25 mg
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiske midler - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
cyclophosphamid "2care4" 200 mg pulver til injektionsvæske, opløsning
2care4 aps - cyclophosphamid, vandfrit - pulver til injektionsvæske, opløsning - 200 mg
sertraline "orifarm" 25 mg filmovertrukne tabletter
orifarm generics a/s - sertralinhydrochlorid - filmovertrukne tabletter - 25 mg
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiske midler - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
orserdu
stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
midazolam "orpha" 15 mg filmovertrukne tabletter
orpha devel handels- und vertr. - midazolam - filmovertrukne tabletter - 15 mg